What is the management of Dieulafoy's lesion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Dieulafoy's Lesion

Endoscopic mechanical therapy with either band ligation or hemoclipping is the first-line treatment for Dieulafoy's lesion, with success rates of 75-100%. 1, 2

Initial Management

  • Aggressive volume resuscitation and hemodynamic stabilization are the first priorities before attempting definitive treatment 1
  • Place two large-bore IV catheters and infuse normal saline to stabilize vital signs 1
  • Blood transfusion is indicated for severe bleeding or when hemoglobin is less than 100 g/L 1

Diagnostic Approach

  • Upper endoscopy should be performed as the first diagnostic study after resuscitation 1
  • Dieulafoy lesions can be difficult to diagnose and may require repeated endoscopy if initial examination is negative 1
  • CT angiography should be considered as a first-line study in hemodynamically unstable patients with suspected active bleeding 1
  • Multiphase CT enterography can help detect Dieulafoy lesions, which are most conspicuous on arterial phase imaging 1

Endoscopic Treatment Options

First-Line Treatment:

  • Mechanical therapy is superior to other endoscopic methods 1, 2
    • Hemoclips are particularly effective for actively bleeding large vessels 1, 3
    • Endoscopic band ligation has similar efficacy to hemoclipping 1, 4

Alternative Options:

  • Injection therapy (epinephrine, hypertonic saline-epinephrine, or pure ethanol) can achieve initial hemostasis but has higher rebleeding rates when used alone 1, 2
  • Thermal methods (heater probe) may be used in combination with injection therapy 4, 5
  • Combination therapy is superior to monotherapy due to lower rates of recurrent bleeding 2

Treatment Success Rates

  • Initial hemostasis can be achieved in 100% of cases with appropriate endoscopic therapy 4, 3
  • Rebleeding rates are low (0-5%) with mechanical methods 3, 6
  • Long-term outcomes are favorable with endoscopic management, with studies showing no recurrence during follow-up periods of 28-47 months 3, 6

Post-Treatment Management

  • High-dose proton pump inhibitor therapy is recommended after successful endoscopic therapy 1
  • Close monitoring of vital signs, including continuous observation of pulse, blood pressure, and urine output 1
  • Patients who are hemodynamically stable 4-6 hours after endoscopy can begin oral intake 1

Management of Refractory Cases

  • For persistent or recurrent bleeding despite initial endoscopic therapy, repeat endoscopic treatment should be attempted 1, 6
  • Angiographic embolization should be considered for cases that fail repeated endoscopic therapy 1, 2
  • Surgical intervention is reserved for cases that fail both endoscopic and angiographic interventions 2

Special Considerations

  • For Dieulafoy lesions in the small intestine beyond the reach of standard endoscopy, deep enteroscopy or intraoperative enteroscopy may be required 1
  • In patients with recurrent bleeding, consider underlying coagulopathies or use of anticoagulant medications 1
  • Advances in endoscopic techniques have reduced mortality in patients with Dieulafoy's lesion from 80% to 8% 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.